Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma
Recruiting
Phase 1
Interventional Study
Safety in Asthma Patients
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 55
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 40 (estimated)
- Sponsor
- Aspeya, Inc. · Industry
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This is a phase 1 study, randomized, double-blind, placebo-controlled, 2 treatment, 2 period crossover study to evaluate the pharmacokinetics, safety, and tolerability of a single inhaled dose of ASY202 in adults with stable asthma.
Following screening, eligible participants will be enrolled and randomized to one of two treatment sequences. Participants will receive a single inhaled dose of ASY20…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18-55 years
* Diagnosed asthma
* Stable asthma treatment
* Non smoker
* BMI 18.5-35 kg/m²
* Women of childbearing potential and men agree to use acceptable contraception
Exclusion Criteria:
* Asthma exacerbation requiring systemic steroids, ER visit, or hospitali…
Contacts